Search Results - G. Ku

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Amivantamab, a bispecific epidermal growth factor receptor and mesenchymal-epithelial transition factor inhibitor, associated with ulcerative intertrigo by Hannah R. Concannon, BS, Robyn G. Ku, BS, Morgan Brazel, MD, Maria Angelica Selim, MD, Amber Fresco, MD

    Published in JAAD Case Reports (2025-12-01)
    Get full text
    Article


  2. 2

    P518: PEDAL/EUPAL INTERNATIONAL COLLABORATION TO IMPROVE THE OUTCOME OF CHILDREN WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA by V. Ceolin, S. Ishimaru, F. Bautista, B. Goemans, E. A. Kolb, L. Di Laurenzio, T. M. Cooper, M. Bakker, J. Wahlstrom, G. Sunkersett, G. Ku, C. Zwaan, D. Reinhardt, G. Nichols

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  3. 3

    P510: THE IMPACT OF POST-REMISSION GRANULOCYTE COLONY-STIMULATING FACTOR USE IN THE PHASE 3 STUDIES OF VENETOCLAX COMBINATION TREATMENTS IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYEL... by C. DiNardo, K. Pratz, P. Panayiotidis, X. Wei, V. Vorobyev, Á. Illés, I. Kim, V. Ivanov, G. Ku, C. L. Miller, M. Zhang, F. Tatsch, J. Potluri, X. Schmidt, C. Recher

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


Search Tools: